The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BRAF inhibitor acquired resistance: A multicenter meta-analysis of the spectrum and clinical implications of resistance mechanisms.
 
Douglas Buckner Johnson
Consulting or Advisory Role - Boston Scientific
 
Alexander M. Menzies
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline
 
Lisa Zimmer
Honoraria - Bristol-Myers Squibb; Merck; MSD; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche Pharma AG; Teva
 
Zeynep Eroglu
No Relationships to Disclose
 
Fei Ye
No Relationships to Disclose
 
Shilin Zhao
No Relationships to Disclose
 
Antje Sucker
No Relationships to Disclose
 
Helen Rizos
No Relationships to Disclose
 
Willy Hugo
No Relationships to Disclose
 
Ralf Gutzmer
Honoraria - Almirall Hermal GmbH; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Galderma; GlaxoSmithKline; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; LEO Pharma; MSD; Novartis; Pfizer; Roche Pharma AG
Research Funding - Johnson & Johnson; Novartis; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche Pharma AG
 
Richard Kefford
No Relationships to Disclose
 
Helen Gogas
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche Pharma AG
 
Xiangju Kong
No Relationships to Disclose
 
Richard A Scolyer
No Relationships to Disclose
 
Levi A. Garraway
No Relationships to Disclose
 
Jeffrey Alan Sosman
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline
 
Antoni Ribas
Stock and Other Ownership Interests - Compugen; Kite, a Gilead company
Consulting or Advisory Role - Amgen; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Merck Sharp & Dohme (Inst)
 
Roger Lo
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
 
Georgina V. Long
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MERCK; Novartis; Provectus; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Dirk Schadendorf
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG
Research Funding - MSD
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG